Literature DB >> 9562318

Delayed Wallerian degeneration and increased neurofilament phosphorylation in sciatic nerves of rats with streptozocin-induced diabetes.

M Terada1, H Yasuda, R Kikkawa.   

Abstract

It is known that Wallerian degeneration (WD) is prerequisite for nerve regeneration, which is impaired in experimental diabetic rats. To elucidate the effect of hyperglycemia on WD, we studied the time course of WD after axotomy in streptozocin-diabetic (DM) and control rats. Sciatic nerves were removed at several time points after axotomy (days 0-24). Morphometric analysis indicated that WD was delayed in DM throughout experimental period. Quantitative immunohistochemical analysis showed that the early recruitment of macrophage did not differ between the two groups, although its late recruitment was significantly decreased in DM at 15 and 24 days post-axotomy, which suggested that the macrophage-associated process did not contribute to delayed WD in diabetes. Immunoblot analysis showed a delay in the degradation of neurofilaments (NFs) in DM during WD. Phosphorylated NFs detected by SMI31 were more recognized in DM, while the opposite was true for unphosphorylated NFs detected by SMI32. Since it is known that the sensitivity of NF to calpain-mediated proteolysis is modulated by its carboxyl-terminal phosphorylation state and phosphorylated NFs are resistant to calpains, we concluded that abnormal NF phosphorylation state in diabetes could be one of the mechanisms by which axonal degeneration was delayed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9562318     DOI: 10.1016/s0022-510x(97)00269-4

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  17 in total

1.  Quantifying nerve architecture in murine and human airways using three-dimensional computational mapping.

Authors:  Gregory D Scott; Allison D Fryer; David B Jacoby
Journal:  Am J Respir Cell Mol Biol       Date:  2012-10-25       Impact factor: 6.914

Review 2.  Neurobiological Opportunities in Diabetic Polyneuropathy.

Authors:  Trevor M Poitras; Easton Munchrath; Douglas W Zochodne
Journal:  Neurotherapeutics       Date:  2021-12-21       Impact factor: 6.088

3.  Beneficial effects of treadmill training in experimental diabetic nerve regeneration.

Authors:  Tais Malysz; Jocemar Ilha; Patrícia Severo do Nascimento; Katia De Angelis; Beatriz D'Agord Schaan; Matilde Achaval
Journal:  Clinics (Sao Paulo)       Date:  2010       Impact factor: 2.365

4.  Regeneration of diabetic axons is enhanced by selective knockdown of the PTEN gene.

Authors:  Bhagat Singh; Vandana Singh; Anand Krishnan; Kurien Koshy; Jose A Martinez; Chu Cheng; Chris Almquist; Douglas W Zochodne
Journal:  Brain       Date:  2014-02-27       Impact factor: 13.501

5.  Advanced Diabetic Neuropathy: A Point of no Return?

Authors:  Petr Boucek
Journal:  Rev Diabet Stud       Date:  2006-11-10

6.  Hyperglycemia triggers abnormal signaling and proliferative responses in Schwann cells.

Authors:  Khaldoun Almhanna; Pamela L Wilkins; James R Bavis; Subash Harwalkar; Liliana N Berti-Mattera
Journal:  Neurochem Res       Date:  2002-11       Impact factor: 3.996

7.  Disrupting insulin signaling in Schwann cells impairs myelination and induces a sensory neuropathy.

Authors:  Amber R Hackett; Amy Strickland; Jeffrey Milbrandt
Journal:  Glia       Date:  2019-11-23       Impact factor: 7.452

8.  Klotho attenuates renal hypertrophy and glomerular injury in Ins2Akita diabetic mice.

Authors:  Hiroyuki Kadoya; Minoru Satoh; Yoshisuke Haruna; Tamaki Sasaki; Naoki Kashihara
Journal:  Clin Exp Nephrol       Date:  2015-11-19       Impact factor: 2.801

9.  The beneficial effects of C-Peptide on diabetic polyneuropathy.

Authors:  Hideki Kamiya; Weixian Zhang; Anders A F Sima
Journal:  Rev Diabet Stud       Date:  2009-11-10

10.  RAGE deficiency improves postinjury sciatic nerve regeneration in type 1 diabetic mice.

Authors:  Judyta K Juranek; Matthew S Geddis; Fei Song; Jinghua Zhang; Jose Garcia; Rosa Rosario; Shi Fang Yan; Thomas H Brannagan; Ann Marie Schmidt
Journal:  Diabetes       Date:  2012-11-19       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.